NAMPT and colon carcinoma: Shats et al. [24] recently reported that intestinal bacteria boost NAD+ production in mammalian tissues through the activity of their enzyme, nicotinamidase (NMASE or PncA), which bypasses NAMPT inhibitors activity, and counteracts the anti-tumor effects of NAMPT inhibitor in a colon carcinoma cell line.